{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:08:01Z","timestamp":1762542481373,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"TU Munich commission for clinical research","award":["C21-11"],"award-info":[{"award-number":["C21-11"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MI 1173\/5-1"],"award-info":[{"award-number":["MI 1173\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union FP7","award":["PacaNet"],"award-info":[{"award-number":["PacaNet"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12943-015-0483-1","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:02:17Z","timestamp":1450396937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Bo","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjia","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Melissa","family":"Schlitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivonne","family":"Regel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Raulefs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Friess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mert","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kleeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph W.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"issue":"9","key":"483_CR1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000478-199209000-00001","volume":"16","author":"DS Klimstra","year":"1992","unstructured":"Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol. 1992;16(9):815\u201337.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"483_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/path.1711460108","volume":"146","author":"J Chen","year":"1985","unstructured":"Chen J, Baithun SI, Ramsay MA. Histogenesis of pancreatic carcinomas: a study based on 248 cases. J Pathol. 1985;146(1):65\u201376.","journal-title":"J Pathol"},{"issue":"3","key":"483_CR3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","volume":"160","author":"SC Abraham","year":"2002","unstructured":"Abraham SC, Wu TT, Hruban RH, Lee JH, Yeo CJ, Conlon K, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/beta-catenin pathway. Am J Pathol. 2002;160(3):953\u201362.","journal-title":"Am J Pathol"},{"issue":"12","key":"483_CR4","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1634\/theoncologist.2011-0231","volume":"16","author":"MA Lowery","year":"2011","unstructured":"Lowery MA, Klimstra DS, Shia J, Yu KH, Allen PJ, Brennan MF, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist. 2011;16(12):1714\u201320.","journal-title":"Oncologist"},{"issue":"2","key":"483_CR5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0033-1356439","volume":"52","author":"U Schempf","year":"2014","unstructured":"Schempf U, Sipos B, Konig C, Malek NP, Bitzer M, Plentz RR. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report. Z Gastroenterol. 2014;52(2):200\u20133.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"483_CR6","first-page":"87","volume":"13","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Ohzato H, Fukunaga M, Imamura H, Furukawa H. Acinar cell carcinoma of the pancreas: a possible role of S-1 as chemotherapy for acinar cell carcinoma. A case report. Jop. 2012;13(1):87\u201390.","journal-title":"Jop"},{"issue":"5","key":"483_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.pan.2013.05.001","volume":"13","author":"FC Cananzi","year":"2013","unstructured":"Cananzi FC, Jayanth A, Lorenzi B, Belgaumkar A, Mochlinski K, Sharma A, et al. \u201cChronic\u201d metastatic pancreatic acinar cell carcinoma. Pancreatology. 2013;13(5):549\u201352.","journal-title":"Pancreatology"},{"issue":"5897","key":"483_CR8","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801\u20136.","journal-title":"Science"},{"issue":"4","key":"483_CR9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/path.4310","volume":"232","author":"Y Jiao","year":"2014","unstructured":"Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, et al. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol. 2014;232(4):428\u201335.","journal-title":"J Pathol"},{"issue":"7092","key":"483_CR10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006;441(7092):424\u201330.","journal-title":"Nature"},{"issue":"2","key":"483_CR11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"7396","key":"483_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012;485(7396):55\u201361.","journal-title":"Nature"},{"issue":"6","key":"483_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/hmg\/7.6.1053","volume":"7","author":"M Slegtenhorst van","year":"1998","unstructured":"van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet. 1998;7(6):1053\u20137.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"483_CR14","first-page":"4766","volume":"58","author":"TL Plank","year":"1998","unstructured":"Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 1998;58(21):4766\u201370.","journal-title":"Cancer Res"},{"issue":"9","key":"483_CR15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4(9):648\u201357.","journal-title":"Nat Cell Biol"},{"issue":"15","key":"483_CR16","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003;17(15):1829\u201334.","journal-title":"Genes Dev"},{"issue":"6021","key":"483_CR17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331(6021):1199\u2013203.","journal-title":"Science"},{"key":"483_CR18","doi-asserted-by":"crossref","unstructured":"Kong B, Wu W, Cheng T, Schlitter AM, Qian C, Bruns P, et al. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras\/Mek\/Erk-induced hyperactive mTOR signalling. Gut. 2015.","DOI":"10.1136\/gutjnl-2014-307616"},{"issue":"24","key":"483_CR19","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-13-0624","volume":"19","author":"D Garcia-Carracedo","year":"2013","unstructured":"Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, et al. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2013;19(24):6830\u201341.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"483_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cell.2008.06.028","volume":"134","author":"AV Budanov","year":"2008","unstructured":"Budanov AV, Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 2008;134(3):451\u201360.","journal-title":"Cell"},{"issue":"7","key":"483_CR21","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","volume":"67","author":"Z Feng","year":"2007","unstructured":"Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 2007;67(7):3043\u201353.","journal-title":"Cancer Res"},{"issue":"9","key":"483_CR22","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1128\/MCB.01695-07","volume":"28","author":"Y Shigeyama","year":"2008","unstructured":"Shigeyama Y, Kobayashi T, Kido Y, Hashimoto N, Asahara S, Matsuda T, et al. Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol. 2008;28(9):2971\u20139.","journal-title":"Mol Cell Biol"},{"issue":"23","key":"483_CR23","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","volume":"26","author":"CH Lee","year":"2007","unstructured":"Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, et al. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. Embo J. 2007;26(23):4812\u201323.","journal-title":"Embo J"},{"issue":"8","key":"483_CR24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.4161\/cc.10.8.15363","volume":"10","author":"AV Pinho","year":"2011","unstructured":"Pinho AV, Rooman I, Real FX. p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle. 2011;10(8):1312\u201321.","journal-title":"Cell Cycle"},{"issue":"23","key":"483_CR25","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","volume":"102","author":"Z Feng","year":"2005","unstructured":"Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci U S A. 2005;102(23):8204\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"483_CR26","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.2337\/db13-0970","volume":"63","author":"A Bartolome","year":"2014","unstructured":"Bartolome A, Kimura-Koyanagi M, Asahara S, Guillen C, Inoue H, Teruyama K, et al. Pancreatic beta-cell failure mediated by mTORC1 hyperactivity and autophagic impairment. Diabetes. 2014;63(9):2996\u20133008.","journal-title":"Diabetes"},{"issue":"11","key":"483_CR27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.neo.2014.08.010","volume":"16","author":"L Ding","year":"2014","unstructured":"Ding L, Han L, Li Y, Zhao J, He P, Zhang W. Neurogenin 3-directed cre deletion of tsc1 gene causes pancreatic acinar carcinoma. Neoplasia. 2014;16(11):909\u201317.","journal-title":"Neoplasia"},{"issue":"2","key":"483_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ydbio.2004.03.013","volume":"270","author":"SE Schonhoff","year":"2004","unstructured":"Schonhoff SE, Giel-Moloney M, Leiter AB. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev Biol. 2004;270(2):443\u201354.","journal-title":"Dev Biol"},{"issue":"6","key":"483_CR29","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 2012;21(6):836\u201347.","journal-title":"Cancer Cell"},{"issue":"31","key":"483_CR30","doi-asserted-by":"crossref","first-page":"32154","DOI":"10.18632\/oncotarget.5168","volume":"6","author":"B Kong","year":"2015","unstructured":"Kong B, Cheng T, Wu W, Regel I, Raulefs S, Friess H, et al. Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer. Oncotarget. 2015;6(31):32154\u201360.","journal-title":"Oncotarget"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-015-0483-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T13:41:59Z","timestamp":1567431719000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-015-0483-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s12943-015-0483-1","relation":{},"ISSN":["1476-4598"],"issn-type":[{"type":"electronic","value":"1476-4598"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"212"}}